drugset / Trial / NCT00996281
Safety and Tolerability of Azilsartan Medoxomil Plus Chlorthalidone Compared to Olmesartan Medoxomil Plus Hydrochlorothiazide in Participants With Essential Hypertension
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the safety and tolerability of azilsartan medoxomil plus chlorthalidone, once daily (QD), versus olmesartan medoxomil-hydrochlorothiazide in adults with essential hypertension.
Timeline
- Start
- 2009-10
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Azilsartan medoxomil | Other / unclassified | 40 mg | Oral |
| Subject | Chlorthalidone | Other / unclassified | 12.5 mg | Oral |
| Comparator | Hydrochlorothiazide | Unknown | 12.5 mg | Oral |
| Comparator | Olmesartan medoxomil | Unknown | 20 mg | Oral |